Skip to main content
OpenTrials
Completed

NCT Number: NCT06390137

Anti-Inflammatory Effects Of Frequency Specific Microcurrent (FSM) In Osteoarthritic Adults

It is hypothesized that application of frequency specific microcurrent can decrease inflammation in osteoarthritis patients resulting in decreased pain and potentially decrease disease progression. Participants will received the microcurrent treatment for one hour and a total of five blood draws to measure inflammatory markers. Participants will also complete a pre and post treatment pain questionnaire.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Robinson Family Clinic

Lakeland, Florida, 33813, United States

About this study

After consent, the participant's height and weight will be measured and body mass index calculated using the Athena Health Patient Portal. Next, the participant will complete a pain questionnaire to capture their baseline level of pain as well as a sign a declaration stating that they have drank a quart of water in the past four hours. Then, the patient will have an intravenous port established in an antecubital vein.

The procedure that are being done for research purposed include five intravenous port blood draws and treatment with frequency specific microcurrent.

The patient will have an intravenous port established in an antecubital vein. A baseline 10 mL blood sample will be taken.

Randomization scheme is as follows - after the block size was determined, all possible balanced combinations of assignment within the block were calculated. Blocks were then randomly chosen to determine the patients' assignment into the groups.

An unblinded research coordinator with no other participation in the study will apply the randomization scheme (example included as attachment) to patients to receive either the active microcurrent treatment or a sham treatment. The active treatment includes turning on a Precision Distributing CustomCARE preprogrammed to produce 40 Hz on channel A and 97 Hz on channel B with 200 µamp alternating current polarity with a sharp square wave slope and placing it in an opaque bag so neither the participant or the study investigators know whether the device is on or off. The sham treatment involves not turning the device on and placing it in the same bag.

The electrical pulses will be sent from the CustomCARE through four, six-foot leads (red, green, yellow, and black) with alligator clips attached to two wet towels dampened with tap water. The participant will be seated in a comfortable chair, and the leads with the wet towels will be placed against bare skin as follows: the red (right side) and green (left side) leads will be attached to a single towel wrapped posteriorly around the back at the level of T10 and the yellow (right side) and black (left side) leads will be attached to a second towel and wrapped anteriorly just below the abdomen and iliac crest.

The participant will be instructed to relax for the next 60 minutes. 10mL of blood will be drawn from the IV port and collected in vacutainer plasma tubes before treatment and at the following timepoints during treatment: 15 minutes, 30 minutes, 45 minutes, 60 minutes. After completion of the treatment, the participant will complete a post-treatment pain scale questionnaire (duration 1 minute). Total study time per participant is two hours.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI > 29.9
  • 18 years of age or older
  • active osteoarthritis diagnosis

Exclusion criteria

  • smoker
  • BMI < 30
  • have taken immune-enhancing dietary supplements or medications for inflammation in the past 10 days
  • have or are currently being treated for any physician-diagnosed immune-modulating disease or disorder other than inflammatory arthritis
  • received chemotherapy within the past year
  • have ever received an FSM treatment with the frequency pair 40 Hz/97 Hz

Treatment and study plan

Frequency Specific Microcurrent

Device

The participant will receive an FSM treatment of 40 Hz on channel A and 97 Hz on channel B at 200 uamp with alternating current with a sharp square wave slope for 60 minutes with body contact points using a single towel wrapped posteriorly around the back at the level of T10 and the yellow (right side) and black (left side) leads will be attached to a second towel and wrapped anteriorly just below the abdomen and iliac crest. The TENS unit will be wrapped in an opaque bag so that the device is indistinguishable from that of the sham treatment.

Other names: E275 Transcutaneous Electrical Nerve Stimulator

Sham microcurrent treatment

Device

The participant will receive a sham FSM treatment with the machine off wrapped in an opaque bag for 60 minutes with body contact points using a single towel wrapped posteriorly around the back at the level of T10 and the yellow (right side) and black (left side) leads will be attached to a second towel and wrapped anteriorly just below the abdomen and iliac crest.

Other names: E275 Transcutaneous Electrical Nerve Stimulator (Machine Off)

Primary outcomes

  1. Interleukin-6

    Time frame: Baseline, during the intervention (15 minutes, 30 minutes, 45 minutes), and immediately after the intervention

    Plasma concentration

Secondary outcomes

  1. Tumor Necrosis Factor Alpha

    Time frame: Baseline, during the intervention (15 minutes, 30 minutes, 45 minutes), and immediately after the intervention

    Plasma concentration

  2. General Pain

    Time frame: Baseline, and immediately after the intervention

    0 - 10 Pain Scale, 10 being the worst pain imaginable and 0 being no pain at all

Sponsors and collaborators

Lead sponsor

Nova Southeastern University

Other

Registry information

Official study title

The Immunomodulatory Effects of Frequency Specific Microcurrent In Obese Osteoarthritic Adults

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 30, 2024
Registry last updated
Jun 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.